Podcast


Presenter: Danielle Perry RN MSc James McCormack BSc (Pharm) Pharm D Joey Ton BScPharm PharmD Mike Allan MD

Podcast: BS Medicine Episode #449 Osteoarthritis – All the Evidence for all the Treatments – PART I
0:00

In episode 449, Mike and James invite Danielle Perry and Joey Ton to go over our osteoarthritis systematic review. We talk about all the evidence around exercise, steroid injections, SNRIs, oral NSAIDs, glucosamine, topical NSAIDs, chondroitin, viscosupplementation, oral opioids, acetaminophen. In fact, the magnitude of benefit is exactly in this order – exercise highest, acetaminophen…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode 56: Fatigue, Part II

In this episode of In the Clinic, the team discusses Leah Sandwich, 64-year-old woman presenting with fatigue. To earn an additional 0.25 credits, please click the link below to complete…
Listen 0.5 credits available

BS Medicine Episode #618: From Nerve Pain to Knee Pain: Gabapentinoids for osteoarthritis

In episode 618, Mike K and James chat with Émélie Braschi who helps us go over, yet again, the evidence for the use of gabapentinoids. This time it is for…
Listen 0.5 credits available

BS Medicine Episode #617: A Whiff of Prevention: Treating Male Partners to Reduce Bacterial Vaginosis Recurrence

In episode 617, Tina and James bring in Caitlin Finley to review the latest trial that attempts to answer the question of does treating male sexual partners of females undergoing…
Listen 0.5 credits available

Presenter(s):

Danielle Perry RN MSc James McCormack BSc (Pharm) Pharm D Joey Ton BScPharm PharmD Mike Allan MD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Danielle Perry RN MSc
  • James McCormack BSc (Pharm) Pharm D
  • Joey Ton BScPharm PharmD
  • Mike Allan MD

Spearkers do not have any conflicts of interest to declare.